All In Biotech

Drug Trial Radar · NCT03502434

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

A Phase 1, Single-Center, Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 223 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

223

Actual

Start

Sep 11, 2017

Primary completion

Nov 17, 2017

Study completion Nov 17, 2017

Sponsor

Lead sponsor
Biosplice Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Apr 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a single center, randomized, controlled, within subject comparison, single dose study to determine the sensitization potential of SM04755 solution on normal skin under semi-occlusive patch conditions.

Conditions

  • Tendinopathy

Interventions

  • SM04755Drug

    Healthcare professional-applied patches to subjects during the Induction Period on Days 1, 3, 5, 8, 10, 12, 15, 17 and 19, and during the Challenge Period on Day 36. Patches are to be worn by the subject for approximately 48-72 hours before removal and reaction grading.

  • VehicleOther

    Healthcare professional-applied patches to subjects during the Induction Period on Days 1, 3, 5, 8, 10, 12, 15, 17 and 19, and during the Challenge Period on Day 36. Patches are to be worn by the subject for approximately 48-72 hours before removal and reaction grading.

  • White PetrolatumOther

    Healthcare professional-applied patches to subjects during the Induction Period on Days 1, 3, 5, 8, 10, 12, 15, 17 and 19, and during the Challenge Period on Day 36. Patches are to be worn by the subject for approximately 48-72 hours before removal and reaction grading.

  • Sodium lauryl sulfateOther

    Healthcare professional-applied patches to subjects during the Induction Period on Days 1, 3, 5, 8, 10, 12, 15, 17 and 19, and during the Challenge Period on Day 36. Patches are to be worn by the subject for approximately 48-72 hours before removal and reaction grading.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Contact sensitization potential of Test Material as measured by Treatment emergentTime frame: Baseline to Day 40 (or through the observation period for TEAEs)
  2. Contact sensitization potential of Test Material as measured by Reaction GradeTime frame: Baseline to Day 38-40
  3. Contact sensitization potential of Test Material as measured by Investigator assessment of irritation and sensitizationTime frame: Baseline to Day 40

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Lynchburg, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.